Publication date: Jun 11, 2024
The RECLAIM study platform will be used to explore whether the use of Hyperbaric Oxygen therapy (HBOT) may be used to improve the symptoms of post covid condition. Hyperbaric oxygen therapy is a well-established medical treatment. HBOT promotes healing by delivering a high concentration of oxygen into the body. This high level of oxygen has a number of known benefits, such as growth of new blood vessels, as well as regulating immune and inflammation responses. It helps protect the brain and other nervous tissue from inflammation. HBOT may also have antiviral effects. Collectively, it has the potential to target the underlying mechanisms believed to play a critical role in the development of Long COVID. Many patients with Long COVID complain of fatigue, brain fog, muscle aches and other symptoms. There is evidence to suggest that these symptoms may be a problem with the blood vessels, resulting in abnormal delivery of oxygen to tissues. Thus, our group is investigating whether HBOT’s ability to improve the delivery of oxygen to tissues may help these symptoms.
| Concepts | Keywords |
|---|---|
| Covid19 | Acute |
| Hospitalization | Adaptive |
| Nervous | Covid |
| Organ | Hbot |
| Toronto | Hyperbaric |
| Integrative | |
| Lingering | |
| Oxygen | |
| Post | |
| Recovering | |
| Symptoms | |
| Test | |
| Therapy | |
| Treatment | |
| Trial |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| drug | DRUGBANK | Oxygen |
| disease | MESH | inflammation |
| disease | MESH | Long COVID |
| disease | VO | age |
| disease | IDO | site |
| disease | VO | time |
| disease | VO | effective |
| disease | VO | organ |
| disease | MESH | Contraindications |
| disease | MESH | Pneumothorax |
| disease | MESH | seizure disorder |
| disease | MESH | otitis media |